Improved blood tests for cancer screening: general or specific? - Wikidata - wikimedia - TriplyDB

Improved blood tests for cancer screening: general or specific?

Improved blood tests for cancer screening: general or specific?

http://www.wikidata.org/entity/Q34086617

about

Comparison of serum human epididymis protein 4 and carbohydrate antigen 125 as markers in ovarian cancer: A meta-analysis.Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis.Building the Evidence Base of Blood-Based Biomarkers for Early Detection of Cancer: A Rapid Systematic Mapping Review.Brain tumour differentiation: rapid stratified serum diagnostics via attenuated total reflection Fourier-transform infrared spectroscopy Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K Gag.The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review.A decade of progress in cancer research

P2860

Q33733786-9CEEDFBE-6F97-4CA2-B914-357AC5866D82 Q34308808-FD0F3EC5-8433-4817-AEC1-068D3E6AF65B Q36079639-FFCA537D-563B-4242-AC3E-5C733A528D61 Q36809344-153F2FEB-E74F-4D4E-A6DB-B9FAF347DC7F Q37635618-21613E9C-21DC-4058-8D42-817BE8B0E05E Q42643973-A5F30C6B-DCC7-4773-9A7E-78FD75BB6B4E Q42693952-910E0259-EB89-4EC7-8894-48FF27BEA807

P2860

Improved blood tests for cancer screening: general or specific?

http://www.wikidata.org/entity/Q34086617

description

2011 nî lūn-bûn

@nan

2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Improved blood tests for cancer screening: general or specific?

@ast

Improved blood tests for cancer screening: general or specific?

@en

Improved blood tests for cancer screening: general or specific?

@nl

type

label

Improved blood tests for cancer screening: general or specific?

@ast

Improved blood tests for cancer screening: general or specific?

@en

Improved blood tests for cancer screening: general or specific?

@nl

prefLabel

Improved blood tests for cancer screening: general or specific?

@ast

Improved blood tests for cancer screening: general or specific?

@en

Improved blood tests for cancer screening: general or specific?

@nl

P1433

Q34086617-C49311C5-F1E1-4B2D-96EC-888951C7E8AC

P1476

Q34086617-EDA331DA-C34D-4945-A75F-CDA2169B8843

P2093

Q34086617-2598778C-B042-4B19-9473-609401431932

P2860

Q34086617-0199E3ED-AEBA-474C-96B6-DF41A3FCFD3F

Q34086617-05167AC4-B003-40AF-834C-CDBADBC725D8

Q34086617-08904FE5-CE64-4E56-A908-A614D1D49F5A

Q34086617-0CA4EB07-F9B5-445C-BFCE-1B4CAC0A5836

Q34086617-16228FA2-0747-44A9-91A0-1348201D6063

Q34086617-3122105C-C806-419E-BF4B-78886843CF27

Q34086617-357ADE1A-06A6-4978-9A79-5D9A44D23D26

Q34086617-38426CB9-77C9-46B2-9D49-E2D5D4398A94

Q34086617-47AD3A5A-E9B9-4FD4-94A4-8BA66908714E

Q34086617-561F3303-EB40-49E3-BC5C-65EB3D2D93E4

P2888

Q34086617-CDEF0455-3BAC-45AB-A6A5-2778E763A975

P304

Q34086617-BBF054B5-ACBE-49E6-8117-A2BB8CF4A127

P31

Q34086617-132a92b7-574a-489c-95da-aaeaf8a7e32b

Q34086617-CB6A1656-39D2-4749-9051-A313142D413A

P356

Q34086617-B008A7B2-3929-46C6-9410-C87F3C8E024F

P407

Q34086617-3382E4D3-B244-4E5C-B16E-193DB985A3AA

P478

Q34086617-4A8905BF-901D-40BE-9C09-5FD9D10B71F7

P577

Q34086617-B1D73891-D905-4C64-BA1A-E9E443D2F084

P5875

Q34086617-EEE22D33-2F99-4E0E-9CD7-EB1993AE7587

P6179

Q34086617-9BDCF725-C0F9-4DBB-BB7C-C045E447A50C

P698

Q34086617-4FC19143-B145-49E1-AEF2-8E179A52D52D

P932

Q34086617-E36F0410-4E93-40CE-A972-341B0D45CBA5

P356

1471-2407-11-499

P1433

P1476

Improved blood tests for cancer screening: general or specific?

@en

P2093

Ian A Cree

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Screening for breast cancer with mammography

Surgery versus radical endotherapies for early cancer and high grade dysplasia in Barrett's oesophagus

Reactivity of a monoclonal antibody with human ovarian carcinoma

Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer

Secretory microRNAs as a versatile communication tool

Circulating mutant DNA to assess tumor dynamics

A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use.

Full-field digital versus screen-film mammography: comparison within the UK breast screening program and systematic review of published data.

Analysis of cancer mutation signatures in blood by a novel ultra-sensitive assay: monitoring of therapy or recurrence in non-metastatic breast cancer

P2888

1471-2407-11-499

P304

499

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-11-499

http://www.w3.org/2001/XMLSchema#string

P407

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51841463

http://www.w3.org/2001/XMLSchema#string

P6179

1009181984

http://www.w3.org/2001/XMLSchema#string

P698

22128772

http://www.w3.org/2001/XMLSchema#string

P932

3285105

http://www.w3.org/2001/XMLSchema#string